Pet Retail, Jewelry and Footwear: Analysts Weigh in on 3 Consumer Comeback Stories
Wall Street analysts are raising flags and price targets on Chewy, Signet Jewelers, and Crocs all at once, but their levels of conviction tell very different stories about which turnaround is actually working.
Three consumer-facing companies are drawing fresh analyst attention as Wall Street reassesses turnaround trajectories across pet e-commerce, jewelry retail and casual footwear.
Morgan Stanley and TD Cowen trimmed price targets on Chewy (NYSE:CHWY | CHWY Price Prediction) while keeping Buy ratings intact. UBS nudged its target higher on Signet Jewelers (NYSE:SIG) following encouraging holiday data. And BTIG initiated coverage on Crocs (NASDAQ:CROX) with a cautious Neutral, acknowledging progress but flagging that the brand recovery still has runway ahead.
Taken together, the moves reflect a Street that sees real improvement in all three names but is calibrating patience differently across each.
| Ticker | Company | Firm | Old Rating → New Rating | New Price Target | One-Line Takeaway |
|---|---|---|---|---|---|
| CHWY | Chewy, Inc. | Morgan Stanley | Buy → Buy | $50 | Target trimmed but conviction holds on share-gain thesis |
| CHWY | Chewy, Inc. | TD Cowen | Buy → Buy | $39 | Lowered target, Buy maintained as e-commerce momentum builds |
| SIG | Signet Jewelers Ltd | UBS | Buy → Buy | $118 (from $115) | Valentine’s Day data and Q4 results support stable outlook |
| CROX | Crocs, Inc. | BTIG | N/A → Neutral | No target | Inventory reset complete, but North American recovery still in progress |
The Analyst’s Case
Morgan Stanley and TD Cowen both trimmed their Chewy price targets but stopped well short of pulling their Buy ratings. The underlying thesis remains intact: Chewy is gaining share in a pet-retail market that analysts project will grow 4.6% annually through 2030. The bullish case rests on rising e-commerce adoption, strengthening autoship trends, and improving customer messaging. With the stock trading around $23.74 on Aug. 26 against Morgan Stanley’s $50 target, the implied upside is substantial even after the trim.
UBS raised its Signet price target to $118 from $115, citing preliminary Q4 results and positive Valentine’s Day trends. The firm expects those data points to keep consensus expectations stable as management prepares to deliver fiscal 2027 guidance. With shares trading around $84.59, Signet trades below the new target with a forward price-to-earnings ratio of just 9x, a notable discount for a brand portfolio that includes Kay Jewelers, Zales, Jared, Blue Nile and James Allen.
BTIG initiated Crocs at Neutral with no price target attached, a signal of genuine uncertainty rather than outright skepticism. The firm acknowledged that Crocs has reset inventory and is driving higher-quality direct-to-consumer growth, but sees the North American Crocs-brand recovery as a roughly year-long process still underway amid competition and continued caution from wholesale partners.
Company Snapshot and Recent Performance
Chewy posted Q3 FY2026 revenue of $3.12 billion, up 8.3% year over year, with autoship sales climbing to $2.61 billion, representing 83.9% of net sales. Adjusted EBITDA grew 30.9% to $180.9 million, and the company generated free cash flow of $175.8 million. Despite the operational progress, the stock is down 20.88% year to date and trades well below its 52-week high of $48.62.
Signet has been the strongest price performer of the three. The company’s Q3 FY2026 results were a standout: revenue of $1.39 billion beat estimates by 1.6%, while adjusted EPS of $0.63 came in well ahead of the $0.29 consensus. Same-store sales rose 3% at Kay, Zales, and Jared, and free cash flow swung from -$75.4 million to +$31 million year over year.
Meanwhile, shares of Crocs traded around $122.65 on Wednesday and are up more than 41% YTD and up nearly 62% from their YTD low on March 20. The flagship Crocs brand posted international growth of 14.1% last quarter, though the HEYDUDE segment remains a drag, with revenue falling 16.9% in Q4 2025 and wholesale down 40.5%.
Why the Move Matters Now
For Chewy, the target cuts from Morgan Stanley and TD Cowen reflect near-term caution on the stock’s trajectory rather than a change in the long-term view. The consensus analyst target sits at $44.27, and 21 of 27 covering analysts rate the stock Buy or Strong Buy with zero Sell ratings. The stock’s forward price-to-earnings ratio of 19x looks reasonable relative to that earnings growth, and the autoship model provides a degree of revenue predictability uncommon in retail.
Signet’s valuation is arguably the most compelling of the three. The forward P/E of 9x is low for a specialty retailer with a demonstrated ability to beat earnings estimates — Q3 FY2026 came in at a 162.5% surprise versus consensus. Management raised full-year guidance to a range of $6.70 to $6.83 billion in total sales and $8.43 to $9.59 in adjusted EPS. The $545 million remaining in share repurchase authorization adds another lever for shareholder returns.
Crocs’ BTIG Neutral signals that the stock is fairly valued at current levels given the uncertainty around HEYDUDE. The company is targeting $100 million in cost savings for 2026 and guiding for adjusted EPS of $12.88 to $13.35 for the full year. The forward P/E of 8x is cheap, but the HEYDUDE goodwill and trademark impairment charge of $737 million in 2025 is a reminder of how costly the acquisition has been.
Key Metrics at a Glance
Signet trades with a forward P/E of 9x and pays a quarterly dividend of $0.32 per share, with approximately $545 million remaining in buyback authorization. Chewy’s autoship model accounts for 83.9% of net sales, providing a degree of revenue predictability uncommon in retail. Crocs management has guided for Q1 2026 revenue to decline between 5.5% and 3.5%, with full-year adjusted EPS guidance of $12.88 to $13.35.
Key Risks to Watch
- Chewy: The stock is trading below its 200-day moving average of $35.88 and has declined 21.52% over the past year. Slowing active customer growth or any deterioration in autoship retention could pressure the turnaround thesis.
- Signet: Management guided Q4 same-store sales conservatively at -5% to +0.5%, and the company faces tariff headwinds, softer consumer confidence, and rising gold costs that could compress margins in fiscal 2027.
- Crocs: HEYDUDE wholesale revenue fell 40.5% in Q4 2025, and the segment’s adjusted g320 basis points to 54.7%. Tariff and trade policy uncertainty adds another variable that could affect sourcing costs across both brands.
This is not personalized financial advice. 247wallst.com and its writers do not own the stocks mentioned. Always do your own due diligence before investing.
Contact [email protected] for any questions or corrections.
Joel South covers large-cap stocks, dividend investing, and major market trends, with a focus on earnings analysis, valuation, and turning complex data into actionable insights for investors.
He brings more than 15 years of experience as an investor and financial journalist, including 12 years at The Motley Fool, where he served as an investment analyst, Bureau Chief, and later led the Fool.com investing news desk. He has also co-hosted an investing podcast and appeared across TV and radio discussing market trends.
